Evaluation of the tubular effects of dapagliflozin using 1HNMR spectroscopy.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Chlortalidone (Primary) ; Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Oct 2017 Status changed from active, no longer recruiting to recruiting.
- 25 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 25 Jan 2016 New trial record